China has announced a crackdown on research fraud, following the retraction of 107 papers published in the journal Tumor Biology.  

The papers were retracted after the journal’s publisher discovered the authors had submitted papers with fake email addresses of reviewers. The 524 authors under investigation, most of whom are clinical cancer specialists, have had their funding from the ministry suspended.

According to STAT, in April this year the Chinese courts approved a new policy calling for strict penalties, including prison sentences and  even the death penalty, for researchers who fabricate data in studies that lead to drug approvals.